BSN medical is a global leader in the worldwide healthcare market specializing in Wound Care & related Vascular diseases, Lymphology and non-invasive Orthopaedic products.
Founded in 2001, we are focused on the development of world-class branded products that offer high quality solutions for our caregivers and patients.
We currently employ approximately 6,000 members of staff and generated revenues at actual rates of €850 m in 2016.
BSN medical aims to provide an integrated therapy-driven approach – grounded in a broad portfolio of products, enhanced by insights into current therapeutic areas and complemented by a progressive approach to partnerships.
Our well-known brands such as Leukoplast®, Cutimed®, JOBST®, Delta and Actimove® are among the most trusted in healthcare. With our comprehensive product portfolio and strong technological competencies, BSN medical addresses patients’ needs in the most prevalent conditions in Wound Care & Vascular diseases and Orthopaedic treatments.
The General Management Committee includes:
Guido Oelkers, PhD, Chief Executive Officer
Jens Kimmig, PhD, Chief Financial Officer
Emil Billbaeck, EVP EMEA
Felix Dahm, MD, EVP Innovation & Strategic Development
Todd Healy, President North America
Sebastian Köhler, Chief Legal Officer & EVP Global Human Resources
Ann Maitland, EVP Global Operations
Norbert Oppitz, EVP Latin America
Erik Trock-Jansen, EVP Asia Pacific
Dale Maxie De Lopes Menezes, Director
Dean Wilfred Menezes, Director
Dieter Holst, Director
Emil Anders Billback, Director
Minoo Hormusji Mody, Director
Ganesh Nair, Managing Director